Navigation Links
Heart Stem Cells Could Revolutionize Cardiac Disease Therapy

Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) have identified a growth factor in heart development that could hold the key to genetic //therapies for cardiovascular diseases.

the study, published in the online edition of the Proceedings of the National Academy of Sciences, focuses on the role of short RNAs in the early stages of organogenesis when the heart is developing. These RNAs also called as miRNAs, could play a key role in the future development of genetic strategies to deal with heart diseases. "Of all the medical disciplines that could potentially benefit from stem cell research, cardiology is among the most promising, but a better understanding of early heart development is crucial in order to move forward to stem cell-mediated therapies," said Deepak Srivastava, MD, GICD director and lead author of the study.

In the current study, researchers used Drosophila fly embryos as the model and identified that a miRNA called miR-1 was responsible for the formation of stem cells that ultimately gave rise to the heart. "miR-1 interferes with expression of a crucial gene that controls whether or not certain progenitor stem cells become heart cells. Thus it could be a target for future gene-mediated therapies to prevent early heart development problems." said Chulan Kwon, PhD, a GICD postdoctoral fellow and a co-author of the study. Zhe Han and Eric N. Olson of the Department of Molecular Biology, University of Texas Southwestern Medical Center were the other co-authors of this study.

Contact:

John Watson
jwatson@gladstone.ucsf.edu
415-734-2019
Gladstone Institutes

'"/>




Page: 1

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Epileptic Seizures Can Be Due to Heart Problem
3. Bypass Heart Surgery Performed Without General Anesthesia
4. New CPR Guidelines issued by Heart Association
5. White Cells Count Can Predict Heart Attack Death Risk
6. Vitamins-The answer to Heart Disease?
7. Fight Heart disease and Pain with Meditation
8. Heart disease in the newborn is related to maternal malnutrition
9. New drug to treat Heart Attack and damaged tissue
10. Heart disease threat starts early in life for Diabetics
11. Mechanical Heart

Post Your Comments:
(Date:11/27/2009)...SUR-SEINE,France,Nov.27/PRNewswire/--TeamGarmin-Sl...dicatedtoethicalsportinganddevelopingthenextgenera...omeTeamGarmin-TransitionswiththeadditionofTransiti...listheworld,sleadingmanufacturerofadaptiveeyewear,...widestselectionofspectaclelensessuchasTransitionsl...
(Date:11/27/2009)... bring unprecedented medical, economic burdens, st...Day News) -- The number of people with diabetes in...next 25 years, a new study predicts. , That wou...eople with the disease, up from 23.7 million today...ple with diabetes will triple, the study also warn...
(Date:11/27/2009)... Specialist manufacturers who use medical...ing millions of dollars by bringing in technology ...asing numbers of pro-active medical manufacturers ...ncept stage of their projects, ensuring that progr...cesses or potentially outdated technology. , ...
(Date:11/26/2009)... years, the number of Americans living with diabet...n in 2009 to 44.1 million in 2034. Over the same p...sing from $113 billion to $336 billion, even with ...ers based at the University of Chicago report in t...er of those with diabetes covered by Medicare will...
(Date:11/26/2009)... No more letters from the North Pole, Tex...ext messages from Santa , ...e operational efficiencies at the North Pole Santa...hildren all over the globe informed of his Christm...rsquo;s research department have identified a larg...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2
...al Systems (NYSE: VAR ) announced today that it ...ar 2009 following the close of regular trading on ... be followed by a teleconference available to all ...formation on the conference call webcast will be a...
...rvices are not being provided in Zimbabwe. The pub...her communicable diseases are rampant. Staggering ...ges of food and fuel. Estimates are that 300,000 p...ak has claimed over 600 lives. , , InterActi...
...treatment, elective procedures, study says , ...could be a shortage of 1,300 general surgeons in t...shortage could increase to 6,000 by 2050, a new Oh...y departments. A shortage of general surgeons mean...
...anical Council (ABC) has officially launched its A... http://www.themeaningoftea.com ) adoption of tea ...ea Dragon Films will provide ABC financial support...ase, one of the most robust and powerful herbal da...
...e will feature two of the most innovative new voic...Activism Week and Personhood Conference Jan. 21-23.../prnh/20081105/DC44231LOGO ) , , The TAW will...d Lila Rose, the UCLA student president of Live ...
...evelop the disease within 5 years, study finds , ...ong people whose brain scans show signs of multipl...ll develop MS within about five years, researchers...lities similar to those that occur in MS. After th...
Other Medicine News:Health News:Varian Medical Systems Schedules First Quarter FY2009 News Release and Conference Call 2Health News:Varian Medical Systems Schedules First Quarter FY2009 News Release and Conference Call 3Health News:U.S. May Soon Face Shortage of General Surgeons 2Health News:Tea Dragon Films is First Adopter in the American Botanical Council's New Adopt-An-Herb Program 2Health News:Tea Dragon Films is First Adopter in the American Botanical Council's New Adopt-An-Herb Program 3Health News:Tea Dragon Films is First Adopter in the American Botanical Council's New Adopt-An-Herb Program 4Health News:A.L.L. Personhood Conference Features Pro-Life New Media Stars 2Health News:MRI Can Spot Presymptomatic MS 2
(Date:11/25/2009)....25/PRNewswire/-- ChemoCentryx,Inc.,announcedtoda...T-1(theProspectiveRandomizedOralTherapyEvaluationi...patientswithmoderate-to-severeCrohn,sdiseasedemons...abilityprofile.Thestudydemonstratedevidenceofclini...dasa70-pointdecreaseintheCrohn,sDiseaseActivityInd...
(Date:11/24/2009)...ewswire-FirstCall/--QuestDiagnosticsIncorporated(N...sting,informationandservices,announcedthatitissche...onferenceinNewYorkCity.Thepresentationisscheduledf..., Duringtheconference,thecompanywillreaffirmits...ingincometoexceed18%ofrevenues,anddilutedearningsp...
(Date:11/24/2009)...wswire/--Inadditiontofamily,friendsandhealth,cance...herThanksgivinggratitudelist. ,, "Theyheardthef...aidofMonday,sverdictstotaling$103millionindamagesa...2,000womennationwidewhohavesuedWyethandPfizerpharm...ndPrempro.Wisneskiandtheothervictimsofhormonethera...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Maryland Woman Thankful for Wyeth Verdicts 2Ovarian Cancer Coalition Partners With Consuelo Vanderbilt Costin 56921 1Ovarian Cancer Coalition Partners With Consuelo Vanderbilt Costin 56921 2Air Quality Sciences Achieves Re Accreditation as the US Indoor Air Quality Testing Partner for Europes Coveted Blue Angel Program 56918 1Air Quality Sciences Achieves Re Accreditation as the US Indoor Air Quality Testing Partner for Europes Coveted Blue Angel Program 56918 2Air Quality Sciences Achieves Re Accreditation as the US Indoor Air Quality Testing Partner for Europes Coveted Blue Angel Program 56918 3AOBO Launches New OTC Product to Treat Throat Inflammation 14001 1AOBO Launches New OTC Product to Treat Throat Inflammation 14001 2
...al , AUSTIN, Texas--(BUSINESS WIRE)--May 30, 2007-...ed today the publication of,data describing the dr...n in a patient with a rare inherited form of cance...isorder characterized by,inherited mutations in th...orted treatment of Li-Fraumeni tumors with a thera...
...2007 - Gilead,Sciences, Inc. (Nasdaq:GILD) today a...udy of aztreonam lysine for inhalation for,the tre...e,pulmonary Pseudomonas aeruginosa (P. aeruginosa)...y 28 from baseline in respiratory,symptoms, as ass...,(CFQ-R), a patient-reported outcome (PRO) tool us...
Other Medicine Technology:Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 2Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 3Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 4Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 2Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 3Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 4Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 5
...ned to treat Achilles tendonitis and plantar fasci...der the foot arch and in back of the heel, the Air... to help reduce swelling and enhance circulation. ... and is simple to apply just slip it on like a so...
2360 SOFT FIT SUEDE FINISH WRIST BRACE
...bow brace has been designed by a team of medical s... motion. ,The SADER II Elbow/Forearm Brace has bee...with adjustable static and dynamic rotation forces...es, Post Surgical loss of Motion, Ulnar Osteotomy,...
XR Cubital Tunnel Elbow Splint
Medicine Products: